Biogen stockBIIB
Biogen trades at $243.93, 5.7% below its 52-week high (Oct 28, 2026). The price is above its 50- and 200-day averages, i.e. in an uptrend. +38.6% year to date, +59.0% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Feb 17, 2027.
Ratings, candles, signals and the screener for BIIB — after you log in
Open the terminalFrequently asked questions about Biogen
What is the Biogen stock price?
At the close on Nov 5, 2026: $243.93 (−4.14% on the day). 52-week high: $258.78 on Oct 28, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Biogen report earnings?
The next quarterly report is on Feb 17, 2027. Last quarter, earnings per share changed −46% year over year, revenue +11%.
Does Biogen pay dividends?
No, Biogen does not pay dividends.
Where does Biogen trade and how to buy it?
Ticker BIIB, exchange Nasdaq, listed since 1983. You can buy it through a broker with access to US exchanges.
Should I buy Biogen now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for BIIB are in the terminal after you log in.